The Health Utilities Index (HUI®): concepts, measurement properties and applications

Health and Quality of Life Outcomes

George Torrance³  David Feeny¹  William Furlong²  John Horsman² 

[1] Institute of Health Economics and University of Alberta, Edmonton, AB, Canada;Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, Canada;Innovus Research Inc., Burlington, ON, Canada

关键词: Review paper;    Utility scores;    Utilities;    Single-attribute;    Quality of life;    QALYs;    Multi-attribute;    HUI3;    HUI2;    HUI;    HRQL;    Health Utilities Index;    Health status;   

Others  :  1217086
DOI  :  10.1186/1477-7525-1-54

 received in 2003-07-31, accepted in 2003-10-16,  发布年份 2003

【 摘 要 】

This is a review of the Health Utilities Index (HUI^®) multi-attribute health-status classification systems, and single- and multi-attribute utility scoring systems. HUI refers to both HUI Mark 2 (HUI2) and HUI Mark 3 (HUI3) instruments. The classification systems provide compact but comprehensive frameworks within which to describe health status. The multi-attribute utility functions provide all the information required to calculate single-summary scores of health-related quality of life (HRQL) for each health state defined by the classification systems. The use of HUI in clinical studies for a wide variety of conditions in a large number of countries is illustrated. HUI provides comprehensive, reliable, responsive and valid measures of health status and HRQL for subjects in clinical studies. Utility scores of overall HRQL for patients are also used in cost-utility and cost-effectiveness analyses. Population norm data are available from numerous large general population surveys. The widespread use of HUI facilitates the interpretation of results and permits comparisons of disease and treatment outcomes, and comparisons of long-term sequelae at the local, national and international levels.

【 授权许可】

   
2003 Horsman et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Patrick DL, Erickson P: Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. NewYork: Oxford University Press; 1993.
• [2]Furlong WJ, Feeny DH, Torrance GW, Barr RD: The Health Utilities Index (HUI®) System for Assessing Health-Related Quality of Life in Clinical Studies. Annals of Medicine 2001, 33(5):375-384.
• [3]Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q: Multiattribute Utility Function for a Comprehensive Health Status Classification System: Health Utilities Index Mark 2. Medical Care 1996, 34(7):702-722.
• [4]Feeny DH, Furlong WJ, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M: Multi-Attribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System. Medical Care 2002, 40(2):113-128.
• [5]Canadian Coordinating Office for Health Technology Assessment: Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Ottawa: The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 2nd edition. 1997. Note: This document is available to be downloaded from http://www.ccohta.ca webcite or ordered by email from [e-mail]
• [6]Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
• [7]Torrance GW, Boyle MH, Horwood SP: Application of Multi-Attribute Utility Theory to Measure Social Preference for Health States. Operations Research 1982, 30(6):1043-1069.
• [8]Boyle MH, Torrance GW, Sinclair JC, Horwood SP: Economic Evaluation of Neonatal Intensive Care of Very-Low Birth-Weight Infants. New England Journal of Medicine 1983, 308(22):1330-1337.
• [9]Feeny DH, Torrance GW, Furlong WJ: Health Utilities Index,. In Quality of Life and Pharmacoeconomics in Clinical Trials. Volume 26. 2nd edition. Edited by Bert Spilker. Philadelphia: Lippincott-Raven Press; 1996::239-252.
• [10]Feeny DH, Furlong WJ, Barr RD, Torrance GW, Rosenbaum P, Weitzman S: A Comprehensive Multiattribute System for Classifying the Health Status of Survivors of Childhood Cancer. Journal of Clinical Oncology 1992, 10(6):923-928.
• [11]Feeny DH, Leiper A, Barr RD, Furlong WJ, Torrance GW, Rosenbaum P, Weitzman S: The Comprehensive Assessment of Health Status in Survivors of Childhood Cancer: Application to High-Risk Acute Lymphoblastic Leukaemia. British Journal of Cancer 1993, 67:1047-1052.
• [12]Barr RD, Pai M, Weitzman S, Feeny DH, Furlong WJ, Rosenbaum P, Torrance GW: A Multi-Attribute Approach to Health Status Measurement and Clinical Management – Illustrated by an Application to Brain Tumors in Childhood. International Journal of Oncology 1994, 4:639-648.
• [13]Barr RD, Feeny DH, Furlong WJ, Weitzman S, Torrance GW: A Preference-Based Approach to Helath-Related Quality of Life In Children with Cancer. International Journal of Pediatric Hematology/Oncology 1995, 2:305-315.
• [14]Neumann PJ, Kuntz KM, Leon J, Araki SS, Hermann RC, Hsu MA, Weinstein MC: Health Utilities and Health States in Alzheimer's Disease: A Cross-Sectional Study of Patients and Caregivers. Medical Care 1999, 37(1):27-32.
• [15]von Neumann J, Morgenstern O: Theory of Games and Economic Behaviour. Princeton NJ: Princeton University Press; 1944.
• [16]Torrance GW, Feeny DH, Furlong WJ: Visual Analog Scales: Do They Have a Role in the Measurement of Preferences for Health States. Medical Decision Making 2001, 21(4):329-334.
• [17]Commonwealth of Australia: Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee: Including Major Submissions Involving Economic Analyses. Canberra: Department of Health and Community Services; 1995.
• [18]Ministry of Public Health, Welfare and Sports, The Netherlands: Dutch Guidelines for Pharmacoeconomic Research. Sickness Funds Council; 1999.
• [19]National Institute for Clinical Excellence (NICE): Technology Appraisal Programme: New Guidance Documents. [http://www.nice.org.uk] webcite 2001.
• [20]Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P, in collaboration with the Canadian Knee OA Study Group: A Prospective, Randomized, Pragmatic Health Outcomes Trial Evaluating the Incorporation of Hylan G-F 20 into the Treatment Paradigm for Patients with Knee Osteoarthritis (Part 2 of 2): Economic Results. Osteoarthritis and Cartilage 2002, 10(7):518-527.
• [21]Barr RD, Furlong WJ, Henwood J, Feeny DH, Wegener J, Walker I, Brain M: Economic Evaluation of Allogenic Bone Marrow Transplantation: A Rudimentary Model to Generate Estimates for the Timely Formulation of Clinical Policy. Journal of Clinical Oncology 1996, 14(5):1413-1420.
• [22]Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N, in collaboration with the Canadian Knee OA Study Group: A Prospective, Randomized, Pragmatic Health Outcomes Trial Evaluating the Incorporation of Hylan G-F 20 into the Treatment Paradigm for Patients with Knee Osteoarthritis (Part 1 of 2): Clinical Results. Osteoarthritis and Cartilage 2002, 10(7):506-517.
• [23]Feeny DH, Blanchard C, Mahon JL, Bourne R, Rorabeck C, Stitt L, Webster-Bogaert S: Comparing Community – Preference-Based and Direct Standard Gamble Utility Scores: Evidence from Elective Total Hip Arthroplasty. International Journal of Technology Assessment in Health Care 2003, 19(2):362-372.
• [24]Grootendorst P, Feeny D, Furlong W: Health Utilities Index Mark 3 Evidence of Construct Validity for Stroke and Arthritis in a Population Health Survey. Medical Care 2000, 38(3):290-299.
• [25]Szecket N, Medin G, Furlong WJ, Feeny DH, Barr RD, Depauw S: Preliminary Translation and Cultural Adaptation of Health Utilities Index Questionnaires for Application in Argentina. International Journal of Cancer 1999, Supplement 12:119-124.
• [26]Felder-Puig R, Frey E, Sonnleithner G, Feeny DH, Gadner H, Barr RD, Furlong WJ, Topf R: German Cross-Cultural Adaptation of the Health Utilities Index and Its Application to a Sample of Childhood Cancer Survivors. European Journal of Pediatrics 2000, 159(4):283-288.
• [27]Wang Q, Chen G: The Health Status of the Singaporean Population As Measured by a Multi-Attribute Health Status System. Singapore Medical Journal 1999, 40(6):389-396.
• [28]Glaser AW, Furlong WJ, Walker DA, Fielding K, Davies K, Feeny DH, Barr RD: Applicability of the Health Utilities Index to a Population of Childhood Survivors of Central Nervous System Tumours in the U.K. European Journal of Cancer 1999, 35(2):256-261.
• [29]Costet N, Le Galès C, Buron C, Kinkor F, Mesbah M, Chwalow J, Clinical and Economic Working Groups, Slama G: French Cross-Cultural Adaptation of the Health Utilities Index Mark 2 (HUI2) and 3 (HUI3) Classification Systems. Quality of Life Research 1998, 7(3):245-256.
• [30]Le Galès C, Buron C, Costet N, Rosman S, Slama G: Development of a Preference-Weighted Health Status Classification System in France: The Health Utilities Index 3. Health Care Management Science 2002, 5(1):41-51.
• [31]Barr RD, Petrie C, Furlong WJ, Rothney M, Feeny DH: Health-Related Quality of Life During Post-Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia in Remission: An Influence of Corticosteroid Therapy. International Journal of Oncology 1997, 11:333-339.
• [32]Blanchard C, Feeny DH, Mahon JL, Bourne R, Rorabeck C, Stitt L, Webster-Bogaert S: Is the Health Utilities Index Responsive in Total Hip Arthroplasty Patients? Journal of Clinical Epidemiology, in press.
• [33]Drummond M: Introducing Economic and Quality of Life Measurements into Clinical Studies. Annals of Medicine 2001, 33(5):344-349.
• [34]Samsa G, Edelman D, Rothman M, Williams GR, Lipscomb J, Matchar D: Determining Clinically Important Differences in Health Status Measures A General Approach with Illustration to the Health Utilities Index Mark II. PharmacoEconomics 1999, 15(2):141-155.
• [35]Norman G, Streiner D: Biostatistics The Bare Essentials. St. Louis, MO: Mosby Year Book; 1994.
• [36]Hawthorne G, Richardson J: Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Rev Pharmacoeconomics Outcomes Res 2001, 1(2):215-228.
• [37]Houle C, Berthelot J-M: A Head-to-Head Comparison of the Health Utilities Index Mark 3 and the EQ-5D for the Population Living in Private Households in Canada. Quality of Life Newsletter 2000, 24:5-6.
• [38]Wells J, Furlong W, Nicosia S, Feeny D, Crocker S, Taylor V: Health Utilities Index (HUI) and Carotid Endarterectomy (CE). In International Congress on Quality of Life in Clinical Practice. 1st edition. Chalkidiki, Thessaloniki, Greece; 2002.